Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stock Ready To Explode!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Jaguar Health Inc (NASDAQ:JAGX) Stock Continues to Trend Lower: Down 14% This Week

Shares of Jaguar Health Inc (NASDAQ:JAGX) have been under pressure over the past few trading sessions. Market Stats On Wednesday, JAGX stock fell 6.90% at $1.62 with more than 2.55 million shares, compared to its average volume of 1.92 million shares. The stock has moved within a range of $1.6100 – 1.7800 after opening trading …

Jaguar Health Inc. (NASDAQ:JAGX) Stock Gains Momentum: How to Trade Now?

Jaguar Health Inc. (NASDAQ:JAGX) jumped 7.5% after announcing that Napo EU S.p.A., the Italian subsidiary of its wholly-owned subsidiary Napo Pharmaceuticals Inc. Dragon SPAC S.p.A. had closed the financing of Dragon SPAC for around €8.83 in gross proceeds. This represents the $10 million previously announced Jaguar funding into Dragon SPAC through direct offering generated funds …

Jaguar Health (NASDAQ:JAGX) Stock Makes a Bullish Move: A Good Buy Now?

Italian subsidiary company of Napo Pharmaceuticals, Dragon SPAC, which is also the wholly owned subsidiary of Jaguar Health (NASDAQ:JAGX) on 19th July, 2021 shared financing for gross proceeds of about,830,000 euros. Net proceeds will be harnessed for funding the company’s contemplated business combination with Napo EU as well as activities of combined Napo EU/Dragon SPAC …

Jaguar Health (NASDAQ:JAGX) Stock Gains Momentum: What To Do Now?

Analyst coverage on Jaguar Health (NASDAQ:JAGX) led to the stock surge on Wednesday. Louise Chen from Cantor Fitzgerald gave a positive news on the stock with an overweight rating. It is worth mentioning that the analyst is the only analyst from Wall Street covering the firm. Cantor Fitzgerald’s bullish rating and a robust price target …